Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 72.92 (-4.62%)
Establishment Labs to Present at Jefferies London Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 72.92 (-4.62%)
Establishment Labs Reports Third Quarter 2025 Financial Results

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 72.92 (-4.62%)
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 72.92 (-4.62%)
Canaccord Genuity Keeps Their Buy Rating on Establishment Labs Holdings (ESTA)

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on Establishment Labs Holdings, with a price target of $60.00. The company’s shares closed yesterday at $44.40.Elevate...

ESTA : 72.92 (-4.62%)
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the...

ESTA : 72.92 (-4.62%)
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced...

ESTA : 72.92 (-4.62%)
Citi Sticks to Its Hold Rating for Establishment Labs Holdings (ESTA)

In a report released on October 3, Joanne Wuensch from Citi maintained a Hold rating on Establishment Labs Holdings, with a price target of $43.00. The company’s shares closed yesterday at $39.33.Elevate...

ESTA : 72.92 (-4.62%)
Mizuho Securities Remains a Buy on Establishment Labs Holdings (ESTA)

Mizuho Securities analyst Anthony Petrone reiterated a Buy rating on Establishment Labs Holdings today and set a price target of $70.00. The company’s shares closed last Friday at $41.43.Elevate Your...

ESTA : 72.92 (-4.62%)
Establishment Labs Amends Credit Agreement with Oaktree

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Establishment...

ESTA : 72.92 (-4.62%)

Barchart Exclusives

The Next Two Years Will Belong To Breakups: Investors Who Miss It Will Miss the Cycle
Alpha is not gone. It is just stuck inside companies that forgot what business they are really in. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar